Close

Rating History for Cerevel Therapeutics (CERE) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for CERE
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/28/2023 Jessica Fye Maintain Neutral
(N/A)		 45.00
(25.00)		  
 		   Details